Drug profile · INN
levoleucovorin calcium
FUSILEV
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
levoleucovorin calcium (FUSILEV) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is levoleucovorin calcium?
levoleucovorin calcium (FUSILEV) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for levoleucovorin calcium?
FUSILEV is a marketed brand name for levoleucovorin calcium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of levoleucovorin calcium?
levoleucovorin calcium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.